Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?

CONCLUSIONS: Concurrent use of dexamethasone and apixaban or rivaroxaban in hospitalized COVID-19 patients with laboratory evidence of COVID coagulopathy should be avoided until higher-quality data are available.PMID:34137279 | DOI:10.1177/10600280211025042

Source: The Annals of Pharmacotherapy - June 17, 2021 Category: Drugs & Pharmacology Authors: Maureen A Smythe Carly Burns Qianyue Liu Candice L Garwood Source Type: research